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Key advances in cancer treatment have led to an increasing number of long-term 
cancer survivors. Knowledge of the long-term effects of cancer treatment of 
leukaemia survivors is to some degree limited. This article investigates the effects of 
the treatment of childhood leukaemia on the quality of life, physical and 
psychological wellbeing and general development of survivors. This article reviews 
current literature to examine existing gaps in knowledge and identify a potential 
focus of future research and clinical practice.   
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Enhanced knowledge of causative factors and the development of effective 
paediatric cancer treatments has drastically improved survival rates.1-4 An increase 
in five year survival rates from < 5% in the 1950s, to > 75% in 2004, indicates the 
vast improvements made5. A consequence of these increased survival rates has 
been subsequent research focus on the long-term effects of paediatric cancer6-7. 
Freyer and Kibrick-Lazear8 stress the importance of prolonged monitoring and 
support of survivors to enable early detection and effective management of quality of 











Leukaemia is the most common malignancy in children, representing almost a third 
of all childhood cancers.9  With the introduction of enhanced treatment regimes, cure 
rates of almost 80% have been achieved for childhood acute lymphoblastic 
leukaemia (ALL).10 Treatment for leukaemia can involve; chemotherapy, 
radiotherapy, bone marrow/ stem cell transplants and steroids. Each modality has 
alternative implications for the future health and development of patients. Therefore, 
the impact of each must be known, to enable well informed treatment decisions.10 As 
survival rates have greatly improved, the benefits of specific treatments need  to take 
account of potential long-term problems.  
 
The volume of current research regarding the chronic health and psychological 
problems faced by survivors of childhood leukaemia is steadily increasing. This is 
due to the improvement in aforementioned survival rates, which enables a greater 
number of participants to be recruited.4   
 
The previous lack of research participants reduced the opportunity for longitudinal 
research needed to establish true long term issues.11 As survival rates continue to 
improve, there will be increasing numbers of available participants for future work. 
Currently, the knowledge base is developing, and numerous primary research 
papers explore this topic.12-14  
 
For the purpose of this review, it is necessary to synthesize the literature to 
determine the focus of future research. Subsequently, this article aims to assess 
information on the chronic effects of treatment on childhood survivors of leukaemia. 
It will consider the physical, psychological and developmental effects of treatment 
and ways in which to manage them.  
 
Survivors of childhood cancer are faced with multiple long-term effects which can 
greatly impact their QOL.15 Around two thirds of survivors experience at least one 
long-term problem, whilst a quarter of survivors face a severe or life threatening late 
effect.16 A number of studies highlight the relationship between treatment modality, 
age at diagnosis and the extent of long-term problems.12,14,17-18 Chronic side effects 
in young patients treated with cranial irradiation appear to be exacerbated, with there 
being fewer chronic side effects noted between chemotherapy regimes.19  
 
QOL 
QOL refers to a person’s all around well being, considering both physical and 
psychosocial health.7  With all cancer treatment there is the risk of acute and chronic 
side effects which may impact on a patient’s QOL in both the short and long term. 
Therefore, considering treatment options in-depth to create the most effective 
treatment plan for each individual is essential. Understanding the risks associated 
with cancer therapies is the first step in improving care for the future.20-22 
 
Physical effects 
The endocrine system is readily affected by cancer treatments, resulting in 
numerous long-term problems.23 The extent of these problems appears to be directly 
related to the treatment modality, with problems rarely seen in those treated with 
chemotherapy only. In contrast, leukaemia patients treated with total body irradiation 
(TBI) and bone marrow transplants (BMT) often experience late endocrine 
disorders.24 Severe growth hormone deficiency (GHD) was seen in 50% of those 
treated with TBI/ BMT, with 56% experiencing thyroid dysfunction (mainly 
hypothyroidism). Steffens et al.24 also found that 40% of males had biological signs 
of altered spermatogenesis, with all of the females treated with TBI/ BMT having 
ovarian failure. The majority of patients studied were on some form of hormone 
replacement therapy with the aim of improving the patient’s QOL. Close long-term 
follow up regarding endocrine function is essential in ensuring survivors are well 
supported.23-26 
  
There is not a clear consensus regarding percentage fat mass. Ness et al.27 found 
the percentage fat mass of leukaemia survivors was significantly higher than the 
expected norms, with percentage skeletal and lean body mass significantly lower. In 
contrast, Tillmann et al.28 did not find a significant difference in percentage fat mass 
between survivors and control subjects. Body mass index (BMI) has been found to 
be significantly higher in female survivors when compared to both the expected 
norms, and control subjects.29 Females treated with high dose cranial irradiation (20 
– 24Gy), at a young age were found to have a 55% chance of being overweight or 
obese in the future.30  
 
Male survivors also demonstrated higher BMIs indicating weight problems. However, 
male control subjects also displayed signs of being overweight.29 Therefore, the 
effect of cancer treatment on male survivors’ body composition is not clear. In terms 
of bone mineral density (BMD), there were no differences between cases and 
controls, except regarding lumbar spine bone density, which was significantly lower 
in survivors.28 No difference in BMD was found between groups who received cranial 
irradiation, and those who did not.31 This highlights the need for childhood survivors, 
especially female, to be given guidance on healthy lifestyles in the long-term to 
reduce the occurrence of obesity. 
 
As a result of higher percentage fat masses, and lower BMD in some cases, 
problems with mobility and strength have been detected. Knee extension strength in 
particular is significantly lower in leukaemia survivors than the expected norms and 
control groups tested.32 As a result, survivors walked significantly shorter distances 
in two minutes, demonstrating their impaired mobility.27 Cranial irradiation was found 
to be related to reduced strength and mobility, particularly in female survivors. One 
explanation for reduced mobility could be the effect cancer (radiation) treatment has 
on motor nerve conduction.33 This study identified a significant difference regarding 
motor nerve conduction and lower extremities, resulting in a lack of knee extension 
strength. Survivors’ balance was also affected by treatment somewhat, with one third 
of patients unable to complete the most challenging task.34 Balance problems 
became clear when vision was removed, and survivors were tested with uneven 
surfaces. These problems pose a potential threat to survivors in terms of physical 
activity. 
 
Physical activity during childhood and adolescent years is very important due to its 
effect on percentage fat mass, and peak bone mass.28 Maximal oxygen uptake 
(VO2max) was significantly lower in survivors indicating a reduced level of physical 
fitness.32 Tillmann et al.28 found survivors to have significantly lower weekly activity 
scores than the control group (geometric mean 50 vs geometric mean 74; p < 0.05). 
Thus demonstrating a possible lower exercise capacity similar to that seen by Jarfelt 
et al31. In this study, male survivors previously treated with cranial irradiation, 
especially with existing GHD, experienced much lower exercise capacities, with no 
differences seen between female groups. Both aerobic and anaerobic exercise 
capacity have been seen to be reduced in leukaemia survivors, along with self 
reported cardio-pulmonary fitness levels.27 In contrast, the subjects in the study by 
Heath, Ramzy and Donath,3 either met or exceeded the national standards for 
physical activity, with the exception of three children out of nineteen. This may 
suggest that with clear education on the importance of physical activity, the effects of 





Psychological and developmental effects 
Glover et al.35 investigated the relationship between cranial irradiation and a 
survivor’s psychological mood. Those diagnosed at a younger age (<12.5 years) 
displayed significantly greater levels of mood disturbance. When investigating ethnic 
differences, the racial and ethnic minority group appear to be greater affected by 
mood disturbance with 34.4% being mood disturbed, compared with 22.5% of 
Caucasian survivors. Almost a quarter of the participants displayed signs of mood 
disturbance. Cranial irradiation does increase the occurrence of mood disturbance, 
however not significantly. Thus suggesting treatment modality is not a direct risk 
factor of mood disturbance.  
 
Cranial irradiation has been shown to increase the extent of neuropsychological 
impairment, especially within male survivors.36 When compared to a chemotherapy 
only group, those previously treated with radiotherapy scored lower in tests for verbal 
Intelligence Quotient (IQ), attention and concentration ability, and memory. Spiegler 
et al.19 also found survivors treated with radiation scored significantly lower in 
arithmetic and reading/ comprehension tests, whereas differences in attention and 
intellect were not detected.37 Thus suggesting that prophylactic cranial irradiation 
increases the risk of survivors experiencing neuropsychological impairment, resulting 
in certain cognitive and intellectual deficits.36 Reduced volumes of white matter 
correspond to greater deficit in intelligence and academic achievement, as a result of 
both cranial irradiation, and chemotherapy to a lesser extent.37  
 
With regards to patients treated with chemotherapy only; selective aspects of 
cognitive functioning are impaired, especially visual processing.38 Intensified courses 
of chemotherapy have been seen to cause extensive deficits regarding attentional 
flexibility, and visuo-motor control.39 Those diagnosed at a younger age appear more 
likely to be affected by certain deficits; however it is unclear as to whether this is as a 
result of a greater susceptibility to chemotherapy drugs.40 Although chemotherapy 
appeared to have little consequences concerning intellectual functioning, two young 
patients out of twenty one did show a decline of greater than 10 IQ points. However, 
greater educational support has been shown to reduce these effects on a survivor’s 
intellectual functioning, thus early interventions can be successful.38 
 
Health related quality of life (HRQOL) is important for survivors of childhood 
leukaemia as a result of their predicted long survival rates. Following the completion 
of the Strength and Difficulties questionnaire (SDQ) for children, no statistically 
significant differences in psychosocial health were seen. However, the SDQ for 
mothers of childhood leukaemia survivors displayed significantly poorer scores in 
terms of emotional symptoms 41. Link et al.42 found there to be no differences in self 
reported QOL, yet a significantly lower level of education was reached. Only 23% of 
survivors reached university level, in comparison to 55% of healthy controls.  In 
contrast, Reinfjell et al.43 concluded that there was a significantly lower HRQOL 
amongst survivors of leukaemia when compared to healthy controls. Intellectual 
functioning was determined to be within the normal range, but lower than that of the 
control group. Fathers of childhood leukaemia survivors were found to be 
significantly more anxious and depressed than control subjects41, indicating the 
importance of providing support for the entire family. Chiou et al.44 found the 
problems experienced by cancer survivors, impacted upon a family’s normal routine, 
as a result of significant impairments across both physical and psychosocial 
domains. 
 
With greater than two thirds of children diagnosed with cancer achieving disease free 
survival, it is essential to be aware of the long-term effects which may arise.45 Early 
detection and interventions can improve the QOL of both cancer survivors and their 
family by relieving pressures and reducing the extent of problems.15 Where cure is 
the aim, it is also necessary that the potential chronic issues do not outweigh the 
advantages. Treatment modality does play a part in the chronic effects experienced, 
therefore treatment plans need to be discussed in depth to provide the best care for 
each patient.46 
 
 Further analysis of the research papers is required, along with the inclusion of 
further samples of literature. With this, clearer conclusions regarding the long-term 
QOL of survivors of childhood leukaemia will be detected. Furthermore, the majority 
of the research papers focused on survivors of ALL and did not include other types 
such as Acute Myeloid Leukaemia and Chronic Myeloid Leukaemia. Other forms of 
leukaemia are rarer thus the research available is limited. Nevertheless, it is 
important to investigate whether there are differences between the long-term effects 
for the different types of leukaemia. 
 
Conclusion 
As a result of this literature review, it is clear that childhood survivors of leukaemia 
face many chronic side effects that can greatly impact upon their QOL. This is 
currently an inevitable consequence of curative treatment received. This highlights 
the importance of long-term follow up, especially for those diagnosed at a young 
age.44 There are clear relationships between the extent of chronic effects, and the 
treatment modality, with cranial irradiation and TBI causing greater impairments.24 
Further research into this area is required to enable health professionals to shape 
the treatment of paediatrics, with the aim of providing them with the best QOL 
possible. The dearth of research surrounding rarer forms of leukaemia also implies 
the need for future research to determine the chronic effects of treatment on patients 
suffering from rare forms of leukaemia.  
 
Future practice must be concerned with long-term QOL as well as curing the short 
term problem. Research suggests that the family is equally affected by a child’s 
treatment and subsequent long-term problems. As a result, guidance and support is 
fundamental to creating a positive atmosphere for each family. Consequently, further 
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